View Financial HealthLighthouse Gold 배당 및 자사주 매입배당 기준 점검 0/6Lighthouse Gold 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-6.3%자사주 매입 수익률총 주주 수익률-6.3%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jan 31Lighthouse Gold Inc. announced that it has received CAD 0.854 million in fundingOn January 29, 2026, Lighthouse Gold Inc. closed the transaction. The company issued 12,200,000 units at a price of CAD 0.07 per unit, for gross proceeds of CAD 854,000. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. All securities issued in connection with the Offering are subject to a statutory hold period of four months plus one day in accordance with Canadian securities legislation. A director of the Company participated in the Offering공시 • Jan 15Lighthouse Gold Inc. announced that it expects to receive CAD 0.7 million in fundingLighthouse Gold Inc announced a non-brokered private placement to issue 10,000,000 units at a price of CAD 0.07 per unit for aggregate gross proceeds of CAD 700,000 on January 15, 2026. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. Completion of the Offering is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). Pursuant to applicable securities law, Securities issued under the Offering will be subject to a hold period which will expire four months and one day from the date of closing of the Offering. The Company anticipates to close the Offering on or about January 29, 2026.공시 • Jul 29Alerio Gold Corp., Annual General Meeting, Sep 24, 2025Alerio Gold Corp., Annual General Meeting, Sep 24, 2025.공시 • Jun 24Alerio Gold Corp. announced that it has received CAD 0.491 million in fundingOn June 23, 2025, Alerio Gold Corp. closed the transaction. The company announced that it has issued 24,550,000 Units at a price of CAD 0.02 per Unit for gross proceeds of CAD 491,000. Each Unit will consist of one common share and one-half of one Share purchase warrant. Each whole Warrant will entitle the holder thereof to acquire one additional Share at a price of CAD 0.05 per Share, for a period of 24 months from the closing date. In connection with the Offering, the Company paid an aggregate cash finder’s fee of CAD 9,920 to eligible arm’s length finders. Pursuant to applicable securities laws, all securities issued under the Private Placement are subject to a statutory hold period until October 24, 2025. The securities to be issued under the Debt Settlement Units and Convertible Notes will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.공시 • Jan 10+ 1 more updateAlerio Gold Corp. Announces Board ChangesAlerio Gold Corp. announced that its board of directors has appointed Ioannis Tsitos as a new director of the Company. Alerio also announced the resignation of Allan Fabbro as director. Mr. Rascan has over 30 years of capital markets experience and brings extensive expertise across institutional sales, brokerage, and executive leadership, having served as director for several publicly traded small-cap companies. Throughout his career, he has consistently driven value creation and championed innovation in emerging industries. As CEO of Liberty Leaf, Mr. Rascan led the company through Health Canada's rigorous licensing process, securing cultivation and processing licenses and achieving a market capitalization of +$100 million. In his role at Nova Mentis Life Science, he spearheaded initiatives, establishing Nova Mentis as the first company to secure orphan drug designation for psilocybin in both the United States and European Union for treating Fragile X Syndrome, a primary genetic cause of autism spectrum disorder (ASD) symptoms. His efforts enabled Canada's first approved Phase IIA clinical study to evaluate oral micro-dose psilocybin therapy for Fragile X Syndrome. Mr. Tsitos has over 35 years of experience in the mining industry, having spent 19 of those years with the BHP Billiton group. In his time in the industry, he has lived and worked in South Africa, Ecuador, Greece and United Kingdom, and has been working in Canada since 2000. Originally a physicist-geophysicist, he left BHP Billiton in 2008, where he had the title of New Business Manager for Minerals Exploration with a global reach, based in Vancouver. He has been instrumental in the identification, negotiation and execution of more than 50 exploration agreements over 11 different commodities with juniors, majors, as well as with state exploration and mining companies. Mr. Tsitos sits on several companies' boards as an Independent Director, has published articles in exploration and mining magazines on relevant topics and has been a strong advocate of anti-corruption policies in the mining industry. Until recently, he was the President of Goldsource Mines, which was sold in mid-2024 to the gold producer, Mako Mining. Mr. Tsitos has also been part of two discovery teams with BHP Billiton in porphyry-copper and nickel-sulphide deposits. He holds a B.Sc. degree in Physics from the University of Athens and a Master's degree in Applied Geophysics and Geology from the University of Birmingham, UK In addition, he has completed management and finance studies as part of an MBA program with Herriot Watt University, Edinburgh.Board Change • Oct 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Feb 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$355k free cash flow). Share price has been highly volatile over the past 3 months (254% average daily change). Revenue is less than US$1m. Market cap is less than US$10m (€1.05m market cap, or US$1.13m). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).Recent Insider Transactions • Dec 16Insider recently bought €83k worth of stockOn the 14th of December, Ray Van Empel bought around 2m shares on-market at roughly €0.041 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €87k more in shares than they have sold in the last 12 months.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Member of the Advisory Board Praveen Varshney was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 3FR 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 3FR 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Lighthouse Gold 배당 수익률 vs 시장3FR의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (3FR)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Metals and Mining)1.4%분석가 예측 (3FR) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 3FR 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 3FR 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 3FR 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 3FR 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 15:15종가2026/05/22 00:00수익2026/02/28연간 수익2025/08/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Lighthouse Gold Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jan 31Lighthouse Gold Inc. announced that it has received CAD 0.854 million in fundingOn January 29, 2026, Lighthouse Gold Inc. closed the transaction. The company issued 12,200,000 units at a price of CAD 0.07 per unit, for gross proceeds of CAD 854,000. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. All securities issued in connection with the Offering are subject to a statutory hold period of four months plus one day in accordance with Canadian securities legislation. A director of the Company participated in the Offering
공시 • Jan 15Lighthouse Gold Inc. announced that it expects to receive CAD 0.7 million in fundingLighthouse Gold Inc announced a non-brokered private placement to issue 10,000,000 units at a price of CAD 0.07 per unit for aggregate gross proceeds of CAD 700,000 on January 15, 2026. Each Unit will be comprised of one common share in the capital of the Company and one-half of one share purchase warrant. Each Warrant is exercisable to purchase one additional Share for a period of 18 months from the closing date at an exercise price of CAD 0.13 per Warrant Share. Completion of the Offering is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). Pursuant to applicable securities law, Securities issued under the Offering will be subject to a hold period which will expire four months and one day from the date of closing of the Offering. The Company anticipates to close the Offering on or about January 29, 2026.
공시 • Jul 29Alerio Gold Corp., Annual General Meeting, Sep 24, 2025Alerio Gold Corp., Annual General Meeting, Sep 24, 2025.
공시 • Jun 24Alerio Gold Corp. announced that it has received CAD 0.491 million in fundingOn June 23, 2025, Alerio Gold Corp. closed the transaction. The company announced that it has issued 24,550,000 Units at a price of CAD 0.02 per Unit for gross proceeds of CAD 491,000. Each Unit will consist of one common share and one-half of one Share purchase warrant. Each whole Warrant will entitle the holder thereof to acquire one additional Share at a price of CAD 0.05 per Share, for a period of 24 months from the closing date. In connection with the Offering, the Company paid an aggregate cash finder’s fee of CAD 9,920 to eligible arm’s length finders. Pursuant to applicable securities laws, all securities issued under the Private Placement are subject to a statutory hold period until October 24, 2025. The securities to be issued under the Debt Settlement Units and Convertible Notes will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.
공시 • Jan 10+ 1 more updateAlerio Gold Corp. Announces Board ChangesAlerio Gold Corp. announced that its board of directors has appointed Ioannis Tsitos as a new director of the Company. Alerio also announced the resignation of Allan Fabbro as director. Mr. Rascan has over 30 years of capital markets experience and brings extensive expertise across institutional sales, brokerage, and executive leadership, having served as director for several publicly traded small-cap companies. Throughout his career, he has consistently driven value creation and championed innovation in emerging industries. As CEO of Liberty Leaf, Mr. Rascan led the company through Health Canada's rigorous licensing process, securing cultivation and processing licenses and achieving a market capitalization of +$100 million. In his role at Nova Mentis Life Science, he spearheaded initiatives, establishing Nova Mentis as the first company to secure orphan drug designation for psilocybin in both the United States and European Union for treating Fragile X Syndrome, a primary genetic cause of autism spectrum disorder (ASD) symptoms. His efforts enabled Canada's first approved Phase IIA clinical study to evaluate oral micro-dose psilocybin therapy for Fragile X Syndrome. Mr. Tsitos has over 35 years of experience in the mining industry, having spent 19 of those years with the BHP Billiton group. In his time in the industry, he has lived and worked in South Africa, Ecuador, Greece and United Kingdom, and has been working in Canada since 2000. Originally a physicist-geophysicist, he left BHP Billiton in 2008, where he had the title of New Business Manager for Minerals Exploration with a global reach, based in Vancouver. He has been instrumental in the identification, negotiation and execution of more than 50 exploration agreements over 11 different commodities with juniors, majors, as well as with state exploration and mining companies. Mr. Tsitos sits on several companies' boards as an Independent Director, has published articles in exploration and mining magazines on relevant topics and has been a strong advocate of anti-corruption policies in the mining industry. Until recently, he was the President of Goldsource Mines, which was sold in mid-2024 to the gold producer, Mako Mining. Mr. Tsitos has also been part of two discovery teams with BHP Billiton in porphyry-copper and nickel-sulphide deposits. He holds a B.Sc. degree in Physics from the University of Athens and a Master's degree in Applied Geophysics and Geology from the University of Birmingham, UK In addition, he has completed management and finance studies as part of an MBA program with Herriot Watt University, Edinburgh.
Board Change • Oct 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Feb 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended May 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$355k free cash flow). Share price has been highly volatile over the past 3 months (254% average daily change). Revenue is less than US$1m. Market cap is less than US$10m (€1.05m market cap, or US$1.13m). Minor Risk Latest financial reports are more than 6 months old (reported May 2023 fiscal period end).
Recent Insider Transactions • Dec 16Insider recently bought €83k worth of stockOn the 14th of December, Ray Van Empel bought around 2m shares on-market at roughly €0.041 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €87k more in shares than they have sold in the last 12 months.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Lee Graber was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Member of the Advisory Board Praveen Varshney was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.